Dilatation and Curettage (D&C)

Subscribe to Selected New Research on Dilatation and Curettage

597 relevant articles (19 outcomes, 55 trials/studies) found for this Therapy

Description: Dilatation of the cervix uteri followed by a scraping of the endometrium with a curette.

Also Known As:

D&C; Curettage and Dilatation; Dilatation & Curettage

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Curettage: 2497

Dilatation and Curettage: 597

Vacuum Curettage: 285

Urogenital Surgical Procedures

Gynecologic Surgical Procedures: 689

Dilatation and Curettage: 597

Vacuum Curettage: 285

Experts

1.	Valentin, L: 2 articles (12/2001 - 10/2001)
2.	Epstein, E: 2 articles (12/2001 - 10/2001)
3.	Skoog, L: 2 articles (12/2001 - 10/2001)
4.	Chang, Kuo-Ming: 1 article (06/2008)
5.	Chang, Shing-Jyh: 1 article (06/2008)
6.	Chen, Chih-Ping: 1 article (06/2008)
7.	Wu, Hong-Ming: 1 article (06/2008)
8.	Ju, W: 1 article (10/2007)
9.	Kim, S C: 1 article (10/2007)
10.	Sierra-Parada, Claudia R: 1 article (07/2007)

Related Diseases

1.	Hemorrhage 12/01/2001 - "CONCLUSION: If there are focal lesions in the uterine cavity, hysteroscopy with endometrial resection is superior to D&C for obtaining a representative endometrial sample in women with postmenopausal bleeding and endometrium > or = 5 mm." 10/01/2001 - "CONCLUSION: Endorette and D&C have similar diagnostic properties in women with postmenopausal bleeding and endometrium < 7 mm. D&C is superior to Endorette in women with endometrium > or =7 mm." 10/01/1994 - "Dilatation and curettage is used as the "gold standard" for diagnosing pathologic endometrial lesions in women with postmenopausal bleeding" 08/01/2002 - "STUDY OBJECTIVE: To compare transvaginal ultrasound, hysteroscopy, and dilation and curettage (D&C) in the evaluation of women with perimenopausal and postmenopausal bleeding" 11/01/2001 - "Rebleeding and endometrial growth in women with postmenopausal bleeding and endometrial thickness < 5 mm managed by dilatation and curettage or ultrasound follow-up: a randomized controlled study." Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 06/01/1987 - "The direct current therapy (D.C.T.) (0.6 mA, 120 min) alone was effective to regress tumor, but tumor was not eradicated by D.C.T" 11/01/2008 - "In a univariable survival analysis, International Federation of Gynecology and Obstetrics (FIGO) tumor stage (P<.001, P<.001), tumor grade (P<.001, P<.001), and patients' age (P<.001, P<.001), but not time interval from D&C to hysterectomy (P=.06, P=.07) were associated with disease-free and overall survival, respectively" 01/01/2006 - "Preoperative tumor grade from D&C or office biopsy may be inaccurate and lead to an underestimate of tumor progression if used to determine which patients should be surgically staged" 09/01/2005 - "We also evaluated the influence of preoperative diagnostic techniques (pipelle and dilation and curettage (D&C)), and the value of transvaginal ultrasound in detecting unexpected tumor invasion" 07/01/2005 - "The accuracy of tumor grade diagnosis by D&C was 50%, and 48% of patients were downgraded after comparison of postoperative specimens" Get all the results and reference details, order at left...
3.	Spontaneous Abortion (Miscarriage) 01/14/1995 - "In a prospective randomised trial we compared the clinical results after either expectant management or D&C, for miscarriages of less than 13 weeks' gestation in which transvaginal ultrasound examination showed intrauterine tissue and/or blood clots with a diameter 15-50 mm. 103 patients were randomised to expectant management and spontaneous resolution of pregnancy occurred within 3 days in 81 cases (79%)" 03/01/2008 - "STUDY DESIGN: This was a cross-sectional analysis comprising 13 patients aged 18-31 years old who had a scheduled dilatation and curettage for a first-trimester miscarriage" 01/01/2006 - "SELECTION CRITERIA: Randomized trials comparing expectant care and surgical treatment (vacuum aspiration or dilation and curettage (D & C)) for miscarriage were eligible for inclusion" 08/01/1996 - "In a prospective randomized trial, we compared psychological reactions and morbidity, after either expectant management or D&C, for miscarriages of < 13 weeks gestation in which a transvaginal ultrasound examination showed intrauterine tissue and/or blood clots with an antero-posterior diameter of between 15 and 50 mm. Of the 86 patients included, 58 were randomized to expectant management and 28 to primary D&C" 01/14/1995 - "This study shows that expectant management of selected cases of spontaneous abortion has a similar outcome to D&C." Get all the results and reference details, order at left...
4.	Endometrial Hyperplasia 01/01/1996 - "In the presented study a group of 140 postmenopausal women has been evaluated and in 10 patients the sonography disclosed endometrial thickness of more than 12 mm. Biopsy in the study group revealed three cases of endometrial hyperplasia and all they were in the patients with uterine lining thicker than 12 mm. In patients taking hormone replacement therapy endometrial thickness of more than 12 mm should be regarded as indication for D&C." 01/01/2003 - "A 53-year-old women underwent D & C and diagnostic hysteroscopy for suspected endometrial hyperplasia, when the posterior uterine wall was perforated" 03/01/1997 - "With C, the sensitivity in histological evaluation was 82% for benign endometrium, 60% for endometrial hyperplasia and 60% for corpus uterine neoplasia as compared to the D&C and hysterectomy material" 01/01/1997 - "63 cases of adenomatous endometrial hyperplasia (1st-3rd degree) were diagnosed by hysteroscopy and D&C at the Department of Obstetrics and Gynaecology of the University of Greifswald from January 1991 to December 1994" 10/01/1979 - "Dilatation and curettage revealed endometrial hyperplasia, and a laparotomy revealed the presence of 2 gonadlike structures" Get all the results and reference details, order at left...
5.	Pain (Aches) 08/01/2007 - "RESULTS: (1) age, professional seniority, diving depth, length of service, dive frequency were positively correlated with the treatment efficacy (P<0.05, P<0.01), and these parameters together with pain intensity were also positively correlated with recurrence risk (P<0.05, P<0.01), while long latency time of the disease often related with poor therapeutic outcome and high recurrence rate (P<0.01), (2) pain intensity were positively affected by age, diving depth and dive frequency (P<0.05, P<0.01), whereas negatively affected by disease latency time (P<0.01), (3) Four elements in this clinic project, selection of treatment program, length of service, diving depth and disease latency time of patient, were responsible for (or: could account for) 48.0% change of treatment efficacy, (4) Among Programs using different therapeutic pressure, Program D, C and B had better outcomes than Program A (P<0.01, P<0.05)" 01/01/2005 - "Pain 2001;91:317-22; Zelman D C, Hoffman D L, Seifeldin R, Dukes, E" 01/01/2005 - "Pain 2001;91:317-22; Zelman D C, Hoffman D L, Seifeldin R, Dukes, E" 10/01/2003 - "For most women, hysteroscopy, dilatation and curettage causes either none or very little pain postoperatively." 11/01/2002 - "A 24-year-old single woman who received a suction dilatation and curettage one week ago developed pain and blurred vision in the right eye" Get all the results and reference details, order at left...
244 Diseases and 597 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Baclofen
2.	Lidocaine (Xylocaine)
3.	Chorionic Gonadotropin (Human Chorionic Gonadotropin)
4.	Dinoprost
5.	Methohexital (Brevital)
6.	P-2 (P 2)
7.	Dexamethasone (Maxidex)
8.	Estrogens (Estrogen)
9.	Misoprostol (Cytotec)
10.	Cyclophosphamide (Cytoxan)
105 Drugs and Important Bio-Agents and 91 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Hysterectomy
2.	Curettage
3.	Cesarean Section (Caesarean Section)
4.	Dilatation and Curettage (D&C)
5.	Vacuum Curettage (Vacuum Pump)
37 Therapies and Procedures and 179 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>